The Food and Drug Administration approved on Friday a label change for Pfizer’s birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain. The Food and Drug Administration approved on Friday a label change for Pfizer’s birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.
FDA approves label change for Depo-Provera, adding brain tumor warningFDA approves label change for Depo-Provera, adding brain tumor warning
